Citations (145)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shivani Jaiswal & Senthil Raja Ayyannan. (2023) Lead optimization study on indoline-2,3-dione derivatives as potential fatty acid amide hydrolase inhibitors. Journal of Biomolecular Structure and Dynamics 41:19, pages 9632-9650.
Read now
Read now
Mengkang Gao, Yusui Wang, Lanqi Liu, Zhenrui Qiao & Lin Yan. (2021) A patent review of transient receptor potential vanilloid type 1 modulators (2014–present). Expert Opinion on Therapeutic Patents 31:2, pages 169-187.
Read now
Read now
Hércules Rezende Freitas, Alinny Rosendo Isaac, Renato Malcher-Lopes, Bruno Lourenço Diaz, Isis Hara Trevenzoli & Ricardo Augusto De Melo Reis. (2018) Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutritional Neuroscience 21:10, pages 695-714.
Read now
Read now
Ludovica Monti, Azzurra Stefanucci, Stefano Pieretti, Francesca Marzoli, Lorenzo Fidanza, Adriano Mollica, Sako Mirzaie, Simone Carradori, Luciano De Petrocellis, Aniello Schiano Moriello, Sándor Benyhe, Ferenc Zádor, Edina Szűcs, Ferenc Ötvös, Anna I. Erdei, Reza Samavati, Szabolcs Dvorácskó, Csaba Tömböly & Ettore Novellino. (2016) Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamates. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1638-1647.
Read now
Read now
Hongfeng Deng. (2010) Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors. Expert Opinion on Drug Discovery 5:10, pages 961-993.
Read now
Read now
Articles from other publishers (140)
Tsung-Jung Ho, Ching-Fang Lin, Jhong-Kuei Chen, Yen-Lun Kung, Li-Kung Wu, Chen-Ying Chang Chien & Chun-Ping Huang. (2023) Electroacupuncture attenuates inflammatory pain via peripheral cannabinoid receptor type 1 signaling pathway in mice. PLOS ONE 18:12, pages e0295432.
Crossref
Crossref
Bala Krishna Prabhala, Jiwan Chettri, Nagalakshmi Irrinki, Abhroop Garg, Rosa Jersie-Christensen, Håvard Jenssen, Biljana Mojsoska, Neeraj Soni & Kristi A. Kohlmeier. (2023) Investigating the effects of a FAAH inhibitor in the laterodorsal tegmental nucleus using a new ex vivo mouse preparation. European Journal of Medicinal Chemistry Reports 9, pages 100111.
Crossref
Crossref
Mallika Tripathy, Amy Bui, Jared Henderson, Jeffrey Sun, Christian Rutan Woods, Soumya Somani, Thao Doan, Anto Sam Crosslee Louis Sam Titus & Chandra Mohan. (2023) FAAH inhibition ameliorates breast cancer in a murine model. Oncotarget 14:1, pages 910-918.
Crossref
Crossref
Shin A Yoon, Yujin Cha, Maxine Mambo Fortibui, Song Yi Yoo, Eun-Young Jo, Chulhun Kang & Min Hee Lee. (2023) In vitro and in vivo imaging of Phase I xenobiotic-metabolizing enzymes. Coordination Chemistry Reviews 491, pages 215248.
Crossref
Crossref
Joanna Lachowicz, Aleksandra Szopa, Katarzyna Ignatiuk, Katarzyna Świąder & Anna Serefko. (2023) Zebrafish as an Animal Model in Cannabinoid Research. International Journal of Molecular Sciences 24:13, pages 10455.
Crossref
Crossref
Shivani Jaiswal, Akhilesh, Vinod Tiwari & Senthil Raja Ayyannan. (2023) Anti-nociceptive potential of an isatin-derived dual fatty acid amide hydrolase-monoacylglycerol lipase inhibitor. Pharmacological Reports 75:3, pages 737-745.
Crossref
Crossref
Marialuisa de Ceglia, Maria Vittoria Micioni Di Bonaventura, Adele Romano, Marzia Friuli, Emanuela Micioni Di Bonaventura, Ana L. Gavito, Luca Botticelli, Silvana Gaetani, Fernando Rodríguez de Fonseca & Carlo Cifani. (2023)
Anxiety associated with palatable food withdrawal is reversed by the selective
FAAH
inhibitor
PF
‐3845: A regional analysis of the contribution of endocannabinoid signaling machinery
. International Journal of Eating Disorders 56:6, pages 1098-1113.
Crossref
Crossref
Nicholas A. Meanwell. (2023) The pyridazine heterocycle in molecular recognition and drug discovery. Medicinal Chemistry Research.
Crossref
Crossref
Kevin A. Scott, Tiffany L. Zhang, Sarah Y. Xi, Bryan Ngo & Ekaterina V. Vinogradova. (2023) Protein State‐Dependent Chemical Biology. Israel Journal of Chemistry 63:3-4.
Crossref
Crossref
Brian J. Lopresti, Sarah K. Royse, Chester A. Mathis, Savannah A. Tollefson & Rajesh Narendran. (2022) Beyond monoamines: I. Novel targets and radiotracers for Positron emission tomography imaging in psychiatric disorders. Journal of Neurochemistry 164:3, pages 364-400.
Crossref
Crossref
Jeannes Angelia, Xiaohui Weng, Aleksei Solomatov, Christopher Chin, Alyssa Fernandez, Paula K. Hudson, Christophe Morisseau, Bruce D. Hammock, Ram Kandasamy & Stevan Pecic. (2023) Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior. Prostaglandins & Other Lipid Mediators 164, pages 106702.
Crossref
Crossref
Ajay P. Nayak, Cali Loblundo & Leonard Bielory. (2023) Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation. The Journal of Allergy and Clinical Immunology: In Practice 11:2, pages 449-457.
Crossref
Crossref
Sukanya Arul Prakash, Ravindar Chinapaka, Martin Luther John, Somnath Dey & Ravi Kanth Kamlekar. (2023)
Crystal structure, molecular packing, and intermolecular interactions of
N
-pentadecanoyltaurine and
N
-acyltaurine's interaction with cholesterol
. CrystEngComm.
Crossref
Crossref
Ram Kandasamy & Stevan Pecic. 2023. Neurobiology and Physiology of the Endocannabinoid System. Neurobiology and Physiology of the Endocannabinoid System
175
187
.
Julius T. Dongdem, Gideon K. Helegbe, Kwame Opare-Asamoah, Cletus A. Wezena & Augustine Ocloo. (2022) Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro. BMC Pharmacology and Toxicology 23:1.
Crossref
Crossref
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Miriam Francavilla, Angelo Reggiani, Natalia Realini, Rita Scarpelli, Daniele Piomelli & Cristina Tassorelli. (2022) Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine. The Journal of Headache and Pain 23:1.
Crossref
Crossref
Hehe Wang, Adam Taouil, Monaf Awwa, Timothy Clement, Chuanzhou Zhu, Jinwoo Kim, Dominick Rendina, Kalani Jayanetti, Atri Maharaj, Liqun Wang, Diane Bogdan, Antonella Pepe, Martin Kaczocha & Iwao Ojima. (2022) SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents. Bioorganic Chemistry 129, pages 106184.
Crossref
Crossref
Bethany A. Crooks, Darrin Mckenzie, Luke C. Cadd, Ciaran J. McCoy, Paul McVeigh, Nikki J. Marks, Aaron G. Maule, Angela Mousley & Louise E. Atkinson. (2022) Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery. Frontiers in Endocrinology 13.
Crossref
Crossref
Maximilian Barth, Stefan Rudolph, Jan Kampschulze, Imke Meyer zu Vilsendorf, Walburga Hanekamp, Dennis Mulac, Klaus Langer & Matthias Lehr. (2022) Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties. ChemMedChem 17:9.
Crossref
Crossref
Tiziana Genovese, Andrea Duranti, Ramona D’Amico, Roberta Fusco, Daniela Impellizzeri, Alessio Filippo Peritore, Rosalia Crupi, Enrico Gugliandolo, Salvatore Cuzzocrea, Rosanna Di Paola, Rosalba Siracusa & Marika Cordaro. (2022) Fatty Acid Amide Hydrolase (FAAH) Inhibition Plays a Key Role in Counteracting Acute Lung Injury. International Journal of Molecular Sciences 23:5, pages 2781.
Crossref
Crossref
Smita Jain, Akansha Bisht, Kanika Verma, Swarnima Negi, Sarvesh Paliwal & Swapnil Sharma. (2021) The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease. Cell Biochemistry and Function 40:2, pages 106-117.
Crossref
Crossref
Stacey Herriage, Guangping Chen & Carey Pope. (2022) Concentration-dependent effects of chlorpyrifos oxon on peroxisome proliferator-activated receptor signaling in MCF-7 cells. Toxicology in Vitro 78, pages 105268.
Crossref
Crossref
Garrison J B Dyck, Zaid H Maayah, Dean T Eurich & Jason R B Dyck. (2022) Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review. Schizophrenia Bulletin Open 3:1.
Crossref
Crossref
Elena V. Kozlova, Bruno Carabelli, Anthony E. Bishay, Rui Liu, Maximillian E. Denys, John C. Macbeth, Varadh Piamthai, Meli'sa S. Crawford, Declan F. McCole, Nicole I. zur Nieden, Ansel Hsiao & Margarita C. Curras-Collazo. (2022) Induction of distinct neuroinflammatory markers and gut dysbiosis by differential pyridostigmine bromide dosing in a chronic mouse model of GWI showing persistent exercise fatigue and cognitive impairment. Life Sciences 288, pages 120153.
Crossref
Crossref
C. Miyabe Shields & Riley D. Kirk. 2022. Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy. Revolutionizing the Potential of Hemp and Its Products in Changing the Global Economy
97
133
.
Stephanie Wilt, Sean Kodani, Leah Valencia, Paula K. Hudson, Stephanie Sanchez, Taylor Quintana, Christophe Morisseau, Bruce D. Hammock, Ram Kandasamy & Stevan Pecic. (2021) Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Bioorganic & Medicinal Chemistry 51, pages 116507.
Crossref
Crossref
Jaswanthi Padala, Shaheen Begum, Bharathi Koganti & Arifa Begum S. K.. (2021) Exploring Quantitative Structure-Activity Relationships (QSARs) for Urea-Based Dual FAAH and sEH Inhibitors. International Journal of Quantitative Structure-Property Relationships 7:2, pages 1-17.
Crossref
Crossref
Serena Montanari, Marco Allarà, Laura Scalvini, Magdalena Kostrzewa, Federica Belluti, Silvia Gobbi, Marina Naldi, Silvia Rivara, Manuela Bartolini, Alessia Ligresti, Alessandra Bisi & Angela Rampa. (2021) New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators. Molecules 26:11, pages 3254.
Crossref
Crossref
Zubair Rehman Nengroo, Aijaz Ahmad, Adil Tantary, Adil Shafi Ganie & Zeshan Umar Shah. (2021) Design and synthesis of fatty acid derived 4-methoxybenzylamides as antimicrobial agents. Heliyon 7:4, pages e06842.
Crossref
Crossref
Amanda K. East, Melissa Y. Lucero & Jefferson Chan. (2021)
New directions of activity-based sensing for
in vivo
NIR imaging
. Chemical Science 12:10, pages 3393-3405.
Crossref
Crossref
Sabela Rodriguez Lopez & Naşide Mangır. (2021) Current standard of care in treatment of bladder pain syndrome/interstitial cystitis. Therapeutic Advances in Urology 13, pages 175628722110224.
Crossref
Crossref
Rosaria Greco, Chiara Demartini, Annamaria Zanaboni, Ilenia Casini, Roberto De Icco, Angelo Reggiani, Alessandra Misto, Daniele Piomelli & Cristina Tassorelli. (2021) Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine. Neurobiology of Disease 147, pages 105157.
Crossref
Crossref
Shravanthi Mouli, Sindhu Ramesh, Manoj Govindarajulu, Mohammed Almaghrabi, Ayaka Fujihashi, Rishi M. Nadar, Julia M. Salamat, Jack Deruiter, Randall C. Clark, Timothy Moore, Satyanarayana R. Pondugula, Dinesh Chandra Agrawal & Muralikrishnan Dhanasekaran. 2021. Medicinal Herbs and Fungi. Medicinal Herbs and Fungi
203
226
.
Adrián Bartoll, Ana Toledano‐Zaragoza, Josefina Casas, Manuel Guzmán, Edward H Schuchman & María Dolores Ledesma. (2020) Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling. EMBO Molecular Medicine 12:11.
Crossref
Crossref
Nathan J. Kolla, R. Mizrahi, K. Karas, C. Wang, R. M. Bagby, S. McMain, A. I. Simpson, P. M. Rusjan, R. Tyndale, S. Houle & I. Boileau. (2020) Elevated fatty acid amide hydrolase in the prefrontal cortex of borderline personality disorder: a [11C]CURB positron emission tomography study. Neuropsychopharmacology 45:11, pages 1834-1841.
Crossref
Crossref
Pretal P. Muldoon, Lois S. Akinola, Joel E. Schlosburg, Aron H. Lichtman, Laura J. Sim-Selley, Anu Mahadevan, Benjamin F. Cravatt & M. Imad Damaj. (2020) Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice. Neuropharmacology 176, pages 108170.
Crossref
Crossref
Stephanie Wilt, Sean Kodani, Thanh N.H. Le, Lato Nguyen, Nghi Vo, Tanya Ly, Mark Rodriguez, Paula K. Hudson, Christophe Morisseau, Bruce D. Hammock & Stevan Pecic. (2020) Development of multitarget inhibitors for the treatment of pain: Design, synthesis, biological evaluation and molecular modeling studies. Bioorganic Chemistry 103, pages 104165.
Crossref
Crossref
Mohammad Amini, Ehsan Saboory, Leila Derafshpour, Ali Fakhari, Joseph C. Wu, Richard Bruggeman, Fatemeh Asgharzadeh & Ali Ahmadalipour. (2020) The impact of sleep deprivation on sexual behaviors and FAAH expression in the prefrontal cortex of male rats. Neuroscience Letters 735, pages 135254.
Crossref
Crossref
Senthilkumar Sadhasivam, Suresh Alankar, Raj Maturi, Ramana V. Vishnubhotla, Mayur Mudigonda, Dhanashri Pawale, Santhosshi Narayanan, Sepideh Hariri, Chithra Ram, Tracy Chang, Janelle Renschler, George Eckert & Balachundhar Subramaniam. (2020) Inner Engineering Practices and Advanced 4-day Isha Yoga Retreat Are Associated with Cannabimimetic Effects with Increased Endocannabinoids and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-9.
Crossref
Crossref
Scott A. Johnson, Damian Rodriguez & Kathryn Allred. (2020) A Systematic Review of Essential Oils and the Endocannabinoid System: A Connection Worthy of Further Exploration. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-13.
Crossref
Crossref
Stephanie R. Wilt, Mark Rodriguez, Thanh N. H. Le, Emily V. Baltodano, Adrian Salas & Stevan Pecic. (2020) Design, microwave‐assisted synthesis, biological evaluation and molecular modeling studies of 4‐phenylthiazoles as potent fatty acid amide hydrolase inhibitors. Chemical Biology & Drug Design 95:5, pages 534-547.
Crossref
Crossref
Adiv A. Johnson. (2020) Lipid Hydrolase Enzymes: Pragmatic Prolongevity Targets for Improved Human Healthspan?. Rejuvenation Research 23:2, pages 107-121.
Crossref
Crossref
Lina A. Dahabiyeh, Eman Y. Abu-rish & Mutasem O. Taha. (2019) Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments. Pharmacological Reports 72:2, pages 435-442.
Crossref
Crossref
Klaus Weber, Rüdiger Häcker, Jerry F. Hardisty, Stephen B. Harris & A. Wallace Hayes. (2020) Oral repeated-dose toxicity studies of BIA 10–2474 in cynomolgus monkeys. Regulatory Toxicology and Pharmacology 111, pages 104547.
Crossref
Crossref
A. Wallace Hayes. (2020) Commentary on BIA 10-2474. Regulatory Toxicology and Pharmacology 111, pages 104541.
Crossref
Crossref
Imdadul Haq & Aruna Kilaru. (2020) An endocannabinoid catabolic enzyme FAAH and its paralogs in an early land plant reveal evolutionary and functional relationship with eukaryotic orthologs. Scientific Reports 10:1.
Crossref
Crossref
Rati Kailash Prasad Tripathi. (2020) A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents. European Journal of Medicinal Chemistry 188, pages 111953.
Crossref
Crossref
Michelle Kem Su Hor, Monica Dzwonkowski, Tesia Kolodziejczyk, Lorne Muir, Nazar Dubchak, Sabina Hochroth, Bhaktasharan Patel, Aaron Wu, Sean Knight, Garrett Smith, Uday Patel, Quentin Remley & Cicily Hummer. 2020. Cannabis in Medicine. Cannabis in Medicine
415
451
.
Aaron Jesuthasan, Daniel Bullock, Rafael González-Cano & Michael Costigan. 2020. Genomics of Pain and Co-Morbid Symptoms. Genomics of Pain and Co-Morbid Symptoms
209
237
.
Manjunath Lamani, Michael S. Malamas, Shrouq I. Farah, Vidyanand G. Shukla, Michael F. Almeida, Catherine M. Weerts, Joseph Anderson, JodiAnne T. Wood, Karen L.G. Farizatto, Ben A. Bahr & Alexandros Makriyannis. (2019) Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology. Bioorganic & Medicinal Chemistry 27:23, pages 115096.
Crossref
Crossref
David Vanda, Paweł Zajdel & Miroslav Soural. (2019) Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases. European Journal of Medicinal Chemistry 181, pages 111569.
Crossref
Crossref
David A Dawson. (2019) Psychosocial and Biological Aspects of Synthetic and Natural FAAH Inhibitors. Edelweiss Journal of Biomedical Research and Review, pages 6-11.
Crossref
Crossref
Xiaohong Chen, Alan Cowan, Saadet Inan, Ellen B. Geller, Joseph J. Meissler, Scott M. Rawls, Ronald J. Tallarida, Christopher S. Tallarida, Mia N. Watson, Martin W. Adler & Toby K. Eisenstein. (2019)
Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB
1
and CB
2
receptors
. British Journal of Pharmacology 176:17, pages 3378-3389.
Crossref
Crossref
Gregg Siegal & Philipp Selenko. (2019) Cells, drugs and NMR. Journal of Magnetic Resonance 306, pages 202-212.
Crossref
Crossref
Mikiei Tanaka, Kazuya Yagyu, Scott Sackett & Yumin Zhang. (2019) Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells. Cells 8:5, pages 491.
Crossref
Crossref
Paul D. Loprinzi, Liye Zou & Hong Li. (2019) The Endocannabinoid System as a Potential Mechanism through which Exercise Influences Episodic Memory Function. Brain Sciences 9:5, pages 112.
Crossref
Crossref
Debnath Bhuniya, Rajendra K. Kharul, Atul Hajare, Nadim Shaikh, Sandeep Bhosale, Sandip Balwe, Fouzia Begum, Siddhartha De, Sonalee Athavankar, Dhananjay Joshi, Vamsi Madgula, Kaushal Joshi, Amol A. Raje, Ashwinkumar V. Meru, Amol Magdum, Kasim A. Mookhtiar & Rashmi Barbhaiya. (2019) Discovery and evaluation of novel FAAH inhibitors in neuropathic pain model. Bioorganic & Medicinal Chemistry Letters 29:2, pages 238-243.
Crossref
Crossref
Shivani Jaiswal, Rati Kailash Prasad Tripathi & Senthil Raja Ayyannan. (2018) Scaffold hopping-guided design of some isatin based rigid analogs as fatty acid amide hydrolase inhibitors: Synthesis and evaluation. Biomedicine & Pharmacotherapy 107, pages 1611-1623.
Crossref
Crossref
László E. Kiss, Alexandre Beliaev, Humberto S. Ferreira, Carla P. Rosa, Maria João Bonifácio, Ana I. Loureiro, Nuno M. Pires, P. Nuno Palma & Patrício Soares‐da‐Silva. (2018) Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase. ChemMedChem 13:20, pages 2177-2188.
Crossref
Crossref
Ashfaq Ahmad, Sara K. Dempsey, Zdravka Daneva, Ningjun Li, Justin L. Poklis, Pin-Lan Li & Joseph K. Ritter. (2018) Modulation of mean arterial pressure and diuresis by renomedullary infusion of a selective inhibitor of fatty acid amide hydrolase. American Journal of Physiology-Renal Physiology 315:4, pages F967-F976.
Crossref
Crossref
Florian M. Dato, Miriam Sheikh, Rocky Z. Uhl, Alexandra W. Schüller, Michaela Steinkrüger, Peter Koch, Jörg-Martin Neudörfl, Michael Gütschow, Bernd Goldfuss & Markus Pietsch. (2018) ω-Phthalimidoalkyl Aryl Ureas as Potent and Selective Inhibitors of Cholesterol Esterase. ChemMedChem 13:17, pages 1833-1847.
Crossref
Crossref
Gabriela Seabra, Ana Caroline B. Falvella, Paul C. Guest, Daniel Martins‐de‐Souza & Valéria de Almeida. (2018) Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains. PROTEOMICS 18:18.
Crossref
Crossref
Charlotte Wang, Jung-Ying Tzeng, Pei-Zhen Wu, Martin Preisig & Chuhsing Kate Hsiao. (2018) Reexamining Dis/Similarity-Based Tests for Rare-Variant Association with Case-Control Samples. Genetics 209:1, pages 105-113.
Crossref
Crossref
V.E. Tóth, Á. Fehér, J. Németh, I. Gyertyán, Z.S. Zádori & K. Gyires. (2018) Modulation of central endocannabinoid system results in gastric mucosal protection in the rat. Brain Research Bulletin 139, pages 224-234.
Crossref
Crossref
Dale L. Boger. (2017) The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry–Biology Interface. The Journal of Organic Chemistry 82:23, pages 11961-11980.
Crossref
Crossref
Stefan Zahov, David Garzinsky, Walburga Hanekamp & Matthias Lehr. (2017) 1-Heteroarylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability. Bioorganic & Medicinal Chemistry 25:3, pages 825-837.
Crossref
Crossref
Shihab Dider, Jiadong Ji, Zheng Zhao & Lei Xie. (2016) Molecular mechanisms involved in the side effects of fatty acid amide hydrolase inhibitors: a structural phenomics approach to proteome-wide cellular off-target deconvolution and disease association. npj Systems Biology and Applications 2:1.
Crossref
Crossref
Irene M. Wohlman, Gabriella M. Composto, Diane E. Heck, Ned D. Heindel, C. Jeffrey Lacey, Christophe D. Guillon, Robert P. Casillas, Claire R. Croutch, Donald R. Gerecke, Debra L. Laskin, Laurie B. Joseph & Jeffrey D. Laskin. (2016) Mustard vesicants alter expression of the endocannabinoid system in mouse skin. Toxicology and Applied Pharmacology 303, pages 30-44.
Crossref
Crossref
Stephen O. Pember, Galo L. Mejia, Theodore J. Price & Robert J. Pasteris. (2016) Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties. Bioorganic & Medicinal Chemistry Letters 26:12, pages 2965-2973.
Crossref
Crossref
Alexandre Beliaev, Humberto S. Ferreira, David A. Learmonth, Maria João Bonifácio, Leonel Torrão, Nuno M. Pires, Patrício Soares-da-Silva & László E. Kiss. (2016) Synthesis and structure–activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility. Pure and Applied Chemistry 88:4, pages 341-347.
Crossref
Crossref
Yoko Shimoda, Masayuki Fujinaga, Akiko Hatori, Joji Yui, Yiding Zhang, Nobuki Nengaki, Yusuke Kurihara, Tomoteru Yamasaki, Lin Xie, Katsushi Kumata, Hideki Ishii & Ming-Rong Zhang. (2016) N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[11C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry 24:4, pages 627-634.
Crossref
Crossref
Tobias Terwege, Walburga Hanekamp, David Garzinsky, Simone König, Oliver Koch & Matthias Lehr. (2016) ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability. ChemMedChem 11:4, pages 429-443.
Crossref
Crossref
Lu Wang, Joji Yui, Qifan Wang, Yiding Zhang, Wakana Mori, Yoko Shimoda, Masayuki Fujinaga, Katsushi Kumata, Tomoteru Yamasaki, Akiko Hatori, Benjamin H. Rotstein, Thomas Lee Collier, Chongzhao Ran, Neil Vasdev, Ming-Rong Zhang & Steven H. Liang. (2015)
Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([
11
C]MPPO) Based on α-Ketoheterocyclic Scaffold
. ACS Chemical Neuroscience 7:1, pages 109-118.
Crossref
Crossref
Biao Chen, Sha-Sha Ge, Yuan-Chao Zhao, Chong Chen & Song Yang. (2016) Activity-based protein profiling: an efficient approach to study serine hydrolases and their inhibitors in mammals and microbes. RSC Advances 6:114, pages 113327-113343.
Crossref
Crossref
Evangelia Bakali, John McDonald, Ruth A. Elliott, David G. Lambert & Douglas G. Tincello. (2015) Cannabinoid receptor expression in the bladder is altered in detrusor overactivity. International Urogynecology Journal 27:1, pages 129-139.
Crossref
Crossref
Isabelle Boileau, Pablo M Rusjan, Belinda Williams, Esmaeil Mansouri, Romina Mizrahi, Vincenzo De Luca, Douglas S Johnson, Alan A Wilson, Sylvain Houle, Stephen J Kish & Junchao Tong. (2015)
Blocking of Fatty Acid Amide Hydrolase Activity with PF-04457845 in Human Brain: A Positron Emission Tomography Study with the Novel Radioligand [
11
C]CURB
. Journal of Cerebral Blood Flow & Metabolism 35:11, pages 1827-1835.
Crossref
Crossref
R Greco, T Bandiera, AS Mangione, C Demartini, F Siani, G Nappi, G Sandrini, A Guijarro, A Armirotti, D Piomelli & C Tassorelli. (2015) Effects of peripheral FAAH blockade on NTG-induced hyperalgesia—evaluation of URB937 in an animal model of migraine. Cephalalgia 35:12, pages 1065-1076.
Crossref
Crossref
Eva M. Marco, Cinzia Rapino, Antonio Caprioli, Franco Borsini, Giovanni Laviola & Mauro Maccarrone. (2015) Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety. PLOS ONE 10:9, pages e0137034.
Crossref
Crossref
Chihiro Nozaki, Astrid Markert & Andreas Zimmer. (2015) Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. European Neuropsychopharmacology 25:8, pages 1388-1396.
Crossref
Crossref
B.J. Casey, Charles E. Glatt & Francis S. Lee. (2015) Treating the Developing versus Developed Brain: Translating Preclinical Mouse and Human Studies. Neuron 86:6, pages 1358-1368.
Crossref
Crossref
Giulio Poli, Niccolò Giuntini, Adriano Martinelli & Tiziano Tuccinardi. (2015) Application of a FLAP-Consensus Docking Mixed Strategy for the Identification of New Fatty Acid Amide Hydrolase Inhibitors. Journal of Chemical Information and Modeling 55:3, pages 667-675.
Crossref
Crossref
Giulia Palermo, Ursula Rothlisberger, Andrea Cavalli & Marco De Vivo. (2015) Computational insights into function and inhibition of fatty acid amide hydrolase. European Journal of Medicinal Chemistry 91, pages 15-26.
Crossref
Crossref
Giampiero Colombano, Clara Albani, Giuliana Ottonello, Alison Ribeiro, Rita Scarpelli, Glauco Tarozzo, Jennifer Daglian, Kwang-Mook Jung, Daniele Piomelli & Tiziano Bandiera. (2015)
O
-(Triazolyl)methyl Carbamates as a Novel and Potent Class of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
. ChemMedChem 10:2, pages 380-395.
Crossref
Crossref
Sérgio F. Sousa, João T. S. Coimbra, Pedro A. Fernandes, Tiziana Marino, Maria J. Ramos & Nino Russo. 2015. Frontiers in Quantum Methods and Applications in Chemistry and Physics. Frontiers in Quantum Methods and Applications in Chemistry and Physics
115
131
.
Simon Nicolussi, Andrea Chicca, Mark Rau, Sabine Rihs, Michael Soeberdt, Christoph Abels & Jürg Gertsch. (2014) Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: From ultrapotent to hyperpotent. Biochemical Pharmacology 92:4, pages 669-689.
Crossref
Crossref
Maria Antonietta De Luca, Valentina Valentini, Zisis Bimpisidis, Fabio Cacciapaglia, Pierluigi Caboni & Gaetano Di Chiara. (2014) Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell. Frontiers in Psychiatry 5.
Crossref
Crossref
Andrey B. Petrenko, Maya Yamazaki, Kenji Sakimura, Masanobu Kano & Hiroshi Baba. (2014) Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. Behavioural Brain Research 271, pages 51-58.
Crossref
Crossref
Katerina Otrubova, Venkat Srinivasan & Dale L. Boger. (2014) Discovery libraries targeting the major enzyme classes: The serine hydrolases. Bioorganic & Medicinal Chemistry Letters 24:16, pages 3807-3813.
Crossref
Crossref
Beat Lutz. 2014. Cannabinoids. Cannabinoids
95
137
.
Aldric T. Hama, Peter Germano, Matthew S. Varghese, Benjamin F. Cravatt, G. Todd Milne, James P. Pearson & Jacqueline Sagen. (2014) Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain. PLoS ONE 9:5, pages e96396.
Crossref
Crossref
Katharine K. Duncan, Katerina Otrubova & Dale L. Boger. (2014) α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: Exploration of conformational constraints in the acyl side chain. Bioorganic & Medicinal Chemistry 22:9, pages 2763-2770.
Crossref
Crossref
J. Fichna, M. Sałaga, J. Stuart, D. Saur, M. Sobczak, H. Zatorski, J. -P. Timmermans, H. B. Bradshaw, K. Ahn & M. A. Storr. (2014) Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides. Neurogastroenterology & Motility 26:4, pages 470-481.
Crossref
Crossref
Chia‐Shan Wu, Daniel Morgan, Chris P Jew, Chris Haskins, Mary‐Jeanette Andrews, Emma Leishman, Corinne M Spencer, Traci Czyzyk, Heather Bradshaw, Ken Mackie & Hui‐Chen Lu. (2014) Long‐term consequences of perinatal fatty acid amino hydrolase inhibition. British Journal of Pharmacology 171:6, pages 1420-1434.
Crossref
Crossref
B M Ignatowska‐Jankowska, S Ghosh, M S Crowe, S G Kinsey, M J Niphakis, R A Abdullah, Q Tao, S T O' Neal, D M Walentiny, J L Wiley, B F Cravatt & A H Lichtman. (2014)
In vivo
characterization of the highly selective monoacylglycerol lipase inhibitor
KML
29: antinociceptive activity without cannabimimetic side effects
. British Journal of Pharmacology 171:6, pages 1392-1407.
Crossref
Crossref
Katerina Otrubova, Benjamin F. Cravatt & Dale L. Boger. (2014) Design, Synthesis, and Characterization of α-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase. Journal of Medicinal Chemistry 57:3, pages 1079-1089.
Crossref
Crossref
Tobias Terwege, Helmut Dahlhaus, Walburga Hanekamp & Matthias Lehr. (2014) ?-Heteroarylalkylcarbamates as inhibitors of fatty acid amide hydrolase (FAAH). Med. Chem. Commun. 5:7, pages 932-936.
Crossref
Crossref
Shujaath Mehdi. 2013. Enzyme Technologies. Enzyme Technologies
81
129
.
Katarzyna Starowicz & Vincenzo Di Marzo. (2013) Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?. European Journal of Pharmacology 716:1-3, pages 41-53.
Crossref
Crossref
Shafaq Sikandar, Ryan Patel, Sital Patel, Sanam Sikander, David L.H. Bennett & Anthony H. Dickenson. (2013) Genes, molecules and patients—Emerging topics to guide clinical pain research. European Journal of Pharmacology 716:1-3, pages 188-202.
Crossref
Crossref
Ping Liu, Terence G. Hamill, Marc Chioda, Harry Chobanian, Selena Fung, Yan Guo, Linda Chang, Raman Bakshi, Qingmei Hong, James Dellureficio, Linus S. Lin, Catherine Abbadie, Jessica Alexander, Hong Jin, Suzanne Mandala, Lin-Lin Shiao, Wenping Li, Sandra Sanabria, David Williams, Zhizhen Zeng, Richard Hajdu, Nina Jochnowitz, Mark Rosenbach, Bindhu Karanam, Maria Madeira, Gino Salituro, Joyce Powell, Ling Xu, Jenna L. Terebetski, Joseph F. Leone, Patricia Miller, Jacquelynn Cook, Marie Holahan, Aniket Joshi, Stacey O’Malley, Mona Purcell, Diane Posavec, Tsing-Bau Chen, Kerry Riffel, Mangay Williams, Richard Hargreaves, Kathleen A. Sullivan, Ravi P. Nargund & Robert J. DeVita. (2013) Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase. ACS Medicinal Chemistry Letters 4:6, pages 509-513.
Crossref
Crossref
Katerina Otrubova, Monica Brown, Michael S. McCormick, Gye W. Han, Scott T. O’Neal, Benjamin F. Cravatt, Raymond C. Stevens, Aron H. Lichtman & Dale L. Boger. (2013) Rational Design of Fatty Acid Amide Hydrolase Inhibitors That Act by Covalently Bonding to Two Active Site Residues. Journal of the American Chemical Society 135:16, pages 6289-6299.
Crossref
Crossref
Giulia Palermo, Pablo Campomanes, Marilisa Neri, Daniele Piomelli, Andrea Cavalli, Ursula Rothlisberger & Marco De Vivo. (2013) Wagging the Tail: Essential Role of Substrate Flexibility in FAAH Catalysis. Journal of Chemical Theory and Computation 9:2, pages 1202-1213.
Crossref
Crossref
Ken Mackie. 2013. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
11
24
.
William T. Berger, Brian P. Ralph, Martin Kaczocha, Jing Sun, Trent E. Balius, Robert C. Rizzo, Samir Haj-Dahmane, Iwao Ojima & Dale G. Deutsch. (2012) Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs. PLoS ONE 7:12, pages e50968.
Crossref
Crossref
Mark S. Tichenor, John M. Keith, William M. Jones, Joan M. Pierce, Jeff Merit, Natalie Hawryluk, Mark Seierstad, James A. Palmer, Michael Webb, Mark J. Karbarz, Sandy J. Wilson, Michelle L. Wennerholm, Filip Woestenborghs, Dominiek Beerens, Lin Luo, Sean M. Brown, Marlies De Boeck, Sandra R. Chaplan & J. Guy Breitenbucher. (2012) Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites. Bioorganic & Medicinal Chemistry Letters 22:24, pages 7357-7362.
Crossref
Crossref
Shakiru O. Alapafuja, Spyros P. Nikas, Indu T. Bharathan, Vidyanand G. Shukla, Mahmoud L. Nasr, Anna L. Bowman, Nikolai Zvonok, Jing Li, Xiaomeng Shi, John R. Engen & Alexandros Makriyannis. (2012) Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase. Journal of Medicinal Chemistry 55:22, pages 10074-10089.
Crossref
Crossref
Marc B. Skaddan, Lei Zhang, Douglas S. Johnson, Aijun Zhu, Kenneth R. Zasadny, Richard V. Coelho, Kyle Kuszpit, Gwen Currier, Kuo-Hsien Fan, Elizabeth M. Beck, Laigao Chen, Susan E. Drozda, Gayatri Balan, Micah Niphakis, Benjamin F. Cravatt, Kay Ahn, Thomas Bocan & Anabella Villalobos. (2012) The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH). Nuclear Medicine and Biology 39:7, pages 1058-1067.
Crossref
Crossref
John P. Huggins, Trevor S. Smart, Stephen Langman, Louise Taylor & Tim Young. (2012) An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee. Pain 153:9, pages 1837-1846.
Crossref
Crossref
A. Caprioli, R. Coccurello, C. Rapino, S. Di Serio, M. Di Tommaso, M. Vertechy, V. Vacca, N. Battista, F. Pavone, M. Maccarrone & F. Borsini. (2012) The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models. Journal of Pharmacology and Experimental Therapeutics 342:1, pages 188-195.
Crossref
Crossref
CJ Fowler. (2012) Monoacylglycerol lipase - a target for drug development?. British Journal of Pharmacology 166:5, pages 1568-1585.
Crossref
Crossref
Katerina Otrubova & Dale L. Boger. (2012) α-Ketoheterocycle-Based Inhibitors of Fatty Acid Amide Hydrolase (FAAH). ACS Chemical Neuroscience 3:5, pages 340-348.
Crossref
Crossref
Micah J. Niphakis, Douglas S. Johnson, T. Eric Ballard, Cory Stiff & Benjamin F. Cravatt. (2011)
O
-Hydroxyacetamide Carbamates as a Highly Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors
. ACS Chemical Neuroscience 3:5, pages 418-426.
Crossref
Crossref
James M. Ritter. (2012) Exploiting modern cannabinoid pharmacology for therapeutic gain?. British Journal of Clinical Pharmacology 73:5, pages 671-673.
Crossref
Crossref
Gai Ling Li, Helen Winter, Rosalin Arends, Gary W. Jay, Vu Le, Tim Young & John P. Huggins. (2012) Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects. British Journal of Clinical Pharmacology 73:5, pages 706-716.
Crossref
Crossref
Christopher J. Fowler. (2012) Anandamide uptake explained?. Trends in Pharmacological Sciences 33:4, pages 181-185.
Crossref
Crossref
J. R. Savinainen, S. M. Saario & J. T. Laitinen. (2011) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2‐arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiologica 204:2, pages 267-276.
Crossref
Crossref
Udeni Yapa, Jeffery J. Prusakiewicz, Ann D. Wrightstone, Lori J. Christine, Joe Palandra, Elizabeth Groeber & Arthur J. Wittwer. (2012) High-performance liquid chromatography–tandem mass spectrometry assay of fatty acid amide hydrolase (FAAH) in blood: FAAH inhibition as clinical biomarker. Analytical Biochemistry 421:2, pages 556-565.
Crossref
Crossref
Seul Ki Lim, Min Jung Park, Jae Cheong Lim, Jong Choon Kim, Ho Jae Han, Gye-Yeop Kim, Benjamin F. Cravatt, Chang Hoon Woo, Seung Jin Ma, Kyung Cheol Yoon & Soo Hyun Park. (2012) Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retianl pigment epithelial cells. Journal of Cellular Physiology 227:2, pages 569-577.
Crossref
Crossref
R.M. Rezende, P. Paiva-Lima, W.G.P. Dos Reis, V.M. Camêlo, A. Faraco, Y.S. Bakhle & J.N. Francischi. (2012) Endogenous Opioid and Cannabinoid Mechanisms Are Involved in the Analgesic Effects of Celecoxib in the Central Nervous System. Pharmacology 89:3-4, pages 127-136.
Crossref
Crossref
M. Angels Estiarte, Russell J. Johnson, Carl J. Kaub, Sumithra Gowlugari, Donogh J. R. O'Mahony, Margaret T. Nguyen, Daniel E. Emerling, Michael G. Kelly, John Kincaid, Fabien Vincent & Matthew A. J. Duncton. (2012) 2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH). MedChemComm 3:5, pages 611.
Crossref
Crossref
Fabio Benigni & Petter Hedlund. (2012) Reply from Authors re: Apostolos Apostolidis. Taming the Cannabinoids: New Potential in the Pharmacologic Control of Lower Urinary Tract Dysfunction. Eur Urol 2012;61:107–109. European Urology 61:1, pages 109-111.
Crossref
Crossref
Stephen D. Roughley, Helen Browne, Alba T. Macias, Karen Benwell, Teresa Brooks, Jalanie D’Alessandro, Zoe Daniels, Sarah Dugdale, Geraint Francis, Ben Gibbons, Terance Hart, Timothy Haymes, Guy Kennett, Sean Lightowler, Natalia Matassova, Howard Mansell, Angela Merrett, Anil Misra, Anthony Padfield, Rachel Parsons, Robert Pratt, Alan Robertson, Heather Simmonite, Kiri Tan, Steven B. Walls & Melanie Wong. (2012) Fatty acid amide hydrolase inhibitors. 3: Tetra-substituted azetidine ureas with in vivo activity. Bioorganic & Medicinal Chemistry Letters 22:2, pages 901-906.
Crossref
Crossref
Beat Lutz. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
219
222
.
Giulia Palermo, Davide Branduardi, Matteo Masetti, Alessio Lodola, Marco Mor, Daniele Piomelli, Andrea Cavalli & Marco De Vivo. (2011) Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas. Journal of Medicinal Chemistry 54:19, pages 6612-6623.
Crossref
Crossref
Clay W Scott, Gaochao Tian, Xiao Hong Yu, Kathy A. Paschetto, Dee E. Wilkins, Luc Meury, Chang Qing Cao, Jeffrey Varnes & Philip D. Edwards. (2011) Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase. European Journal of Pharmacology 667:1-3, pages 74-79.
Crossref
Crossref
Rita Romani, Roberta Galeazzi, Gabriella Rosi, Rosamaria Fiorini, Irene Pirisinu, Annarina Ambrosini & Giovanna Zolese. (2011) Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids?. Biochimie 93:9, pages 1584-1591.
Crossref
Crossref
Maria-Paz Viveros, Francisco-Javier Bermúdez-Silva, Ana-Belén Lopez-Rodriguez & Edward J. Wagner. (2011) The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. Pharmaceuticals 4:8, pages 1101-1136.
Crossref
Crossref
Katerina Otrubova, Cyrine Ezzili & Dale L. Boger. (2011) The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters 21:16, pages 4674-4685.
Crossref
Crossref
Chia-Shan Wu, Christopher P Jew & Hui-Chen Lu. (2011) Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurology 6:4, pages 459-480.
Crossref
Crossref
Aron H. Lichtman & Victoria Chapman. (2011) A FAAH-fetched approach to treat osteoarthritis pain. Pain 152:5, pages 959-960.
Crossref
Crossref
Cyrine Ezzili, Mauro Mileni, Nicholas McGlinchey, Jonathan Z. Long, Steven G. Kinsey, Dustin G. Hochstatter, Raymond C. Stevens, Aron H. Lichtman, Benjamin F. Cravatt, Edward J. Bilsky & Dale L. Boger. (2011) Reversible Competitive α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Containing Additional Conformational Constraints in the Acyl Side Chain: Orally Active, Long-Acting Analgesics. Journal of Medicinal Chemistry 54:8, pages 2805-2822.
Crossref
Crossref
Mauro Mileni, Joie Garfunkle, Cyrine Ezzili, Benjamin F. Cravatt, Raymond C. Stevens & Dale L. Boger. (2011) Fluoride-Mediated Capture of a Noncovalent Bound State of a Reversible Covalent Enzyme Inhibitor: X-ray Crystallographic Analysis of an Exceptionally Potent α-Ketoheterocycle Inhibitor of Fatty Acid Amide Hydrolase. Journal of the American Chemical Society 133:11, pages 4092-4100.
Crossref
Crossref
Stefan Zahov, Andreas Drews, Mark Hess, Alwine Schulze Elfringhoff & Matthias Lehr. (2011)
1‐(3‐Biaryloxy‐2‐oxopropyl)indole‐5‐carboxylic Acids and Related Compounds as Dual Inhibitors of Human Cytosolic Phospholipase A
2
α and Fatty Acid Amide Hydrolase
. ChemMedChem 6:3, pages 544-549.
Crossref
Crossref
Douglas S. Johnson, Cory Stiff, Scott E. Lazerwith, Suzanne R. Kesten, Lorraine K. Fay, Mark Morris, David Beidler, Marya B. Liimatta, Sarah E. Smith, David T. Dudley, Nalini Sadagopan, Shobha N. Bhattachar, Stephen J. Kesten, Tyzoon K. Nomanbhoy, Benjamin F. Cravatt & Kay Ahn. (2010) Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Medicinal Chemistry Letters 2:2, pages 91-96.
Crossref
Crossref
Jonathan Z. Long, Melanie LaCava, Xin Jin & Benjamin F. Cravatt. (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. Journal of Lipid Research 52:2, pages 337-344.
Crossref
Crossref
Philippe G. Nantermet & Darrell A. Henze. 2011.
19
32
.
Sonia Gattinoni, Chiara De Simone, Sabrina Dallavalle, Filomena Fezza, Raffaella Nannei, Natalia Battista, Patrizia Minetti, Gianandrea Quattrociocchi, Antonio Caprioli, Franco Borsini, Walter Cabri, Sergio Penco, Lucio Merlini & Mauro Maccarrone. (2010) A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4406-4411.
Crossref
Crossref
Douglas S JohnsonEranthie Weerapana & Benjamin F Cravatt. (2010) Strategies for discovering and derisking covalent, irreversible enzyme inhibitors. Future Medicinal Chemistry 2:6, pages 949-964.
Crossref
Crossref
Sonia Gattinoni, Chiara De Simone, Sabrina Dallavalle, Filomena Fezza, Raffaella Nannei, Daniele Amadio, Patrizia Minetti, Gianandrea Quattrociocchi, Antonio Caprioli, Franco Borsini, Walter Cabri, Sergio Penco, Lucio Merlini & Mauro Maccarrone. (2010) Enol Carbamates as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) Endowed with High Selectivity for FAAH over the Other Targets of the Endocannabinoid System. ChemMedChem 5:3, pages 357-360.
Crossref
Crossref
Mauro Mileni, Joie Garfunkle, Cyrine Ezzili, F. Scott Kimball, Benjamin F. Cravatt, Raymond C. Stevens & Dale L. Boger. (2009) X-ray Crystallographic Analysis of α-Ketoheterocycle Inhibitors Bound to a Humanized Variant of Fatty Acid Amide Hydrolase. Journal of Medicinal Chemistry 53:1, pages 230-240.
Crossref
Crossref